Form 4: Heartflow CEO John Farquhar Executes Stock Sale

Heartflow, Inc. CEO John C.M. Farquhar sold 22,562 shares of common stock at $29.12 per share via a 10b5-1 plan.

Summary

• CEO John C.M. Farquhar sold 22,562 shares of Heartflow, Inc. common stock.
• The transaction occurred on May 11, 2026, at a price of $29.12 per share.
• Following the sale, the CEO retains beneficial ownership of 519,397 shares.
• The sale was executed under a pre-established Rule 10b5-1 trading plan adopted on September 12, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed under a pre-planned, non-discretionary trading arrangement.

Positives

• The sale was conducted through a pre-planned Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without triggering insider trading concerns.

Negatives

• The transaction represents a reduction in the CEO's direct equity stake in the company.

Risks

• Executive stock sales can sometimes be perceived negatively by the market as a signal of management's view on the company's valuation.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that executive stock sales via 10b5-1 plans are routine corporate governance events and generally do not reflect a change in company strategy or fundamental health.

Comparison to Industry Standards

• The use of a 10b5-1 plan is the industry standard for executives to manage personal liquidity while maintaining compliance with SEC regulations.

Stakeholder Impact

• Minimal impact expected as the sale was pre-planned and represents a small portion of the CEO's total holdings.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Heartflow, HTFL, Insider Trading, Form 4, Executive Compensation, Stock Sale